342 related articles for article (PubMed ID: 28738364)
1. Risk Factors for Community-Acquired Pneumonia in Adults: A Systematic Review of Observational Studies.
Almirall J; Serra-Prat M; Bolíbar I; Balasso V
Respiration; 2017; 94(3):299-311. PubMed ID: 28738364
[TBL] [Abstract][Full Text] [Related]
2. Community-acquired pneumonia in the elderly.
Fung HB; Monteagudo-Chu MO
Am J Geriatr Pharmacother; 2010 Feb; 8(1):47-62. PubMed ID: 20226392
[TBL] [Abstract][Full Text] [Related]
3. New evidence of risk factors for community-acquired pneumonia: a population-based study.
Almirall J; Bolíbar I; Serra-Prat M; Roig J; Hospital I; Carandell E; Agustí M; Ayuso P; Estela A; Torres A;
Eur Respir J; 2008 Jun; 31(6):1274-84. PubMed ID: 18216057
[TBL] [Abstract][Full Text] [Related]
4. Aetiology of, and risk factors for, recurrent community-acquired pneumonia.
Garcia-Vidal C; Carratalà J; Fernández-Sabé N; Dorca J; Verdaguer R; Manresa F; Gudiol F
Clin Microbiol Infect; 2009 Nov; 15(11):1033-8. PubMed ID: 19673961
[TBL] [Abstract][Full Text] [Related]
5. Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study.
Vissink CE; Huijts SM; de Wit GA; Bonten MJ; Mangen MJ
BMC Infect Dis; 2016 Sep; 16(1):466. PubMed ID: 27589847
[TBL] [Abstract][Full Text] [Related]
6. Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience.
Baldo V; Cocchio S; Gallo T; Furlan P; Romor P; Bertoncello C; Buja A; Baldovin T
PLoS One; 2016; 11(11):e0166637. PubMed ID: 27846277
[TBL] [Abstract][Full Text] [Related]
7. Pneumococcal and influenza vaccination status of hospitalized adults with community acquired pneumonia and the effects of vaccination on clinical presentation.
Demirdogen Cetinoglu E; Uzaslan E; Sayıner A; Cilli A; Kılınc O; Sakar Coskun A; Hazar A; Kokturk N; Filiz A; Polatli M;
Hum Vaccin Immunother; 2017 Sep; 13(9):2072-2077. PubMed ID: 28708954
[TBL] [Abstract][Full Text] [Related]
8. Post hoc analysis of the efficacy of the 13-valent pneumococcal conjugate vaccine against vaccine-type community-acquired pneumonia in at-risk older adults.
Suaya JA; Jiang Q; Scott DA; Gruber WC; Webber C; Schmoele-Thoma B; Hall-Murray CK; Jodar L; Isturiz RE
Vaccine; 2018 Mar; 36(11):1477-1483. PubMed ID: 29429807
[TBL] [Abstract][Full Text] [Related]
9. Microbiology and risk factors for community-acquired pneumonia.
Sanz Herrero F; Blanquer Olivas J
Semin Respir Crit Care Med; 2012 Jun; 33(3):220-31. PubMed ID: 22718208
[TBL] [Abstract][Full Text] [Related]
10. Environmental risk factors for community-acquired pneumonia hospitalization in older adults.
Loeb M; Neupane B; Walter SD; Hanning R; Carusone SC; Lewis D; Krueger P; Simor AE; Nicolle L; Marrie TJ
J Am Geriatr Soc; 2009 Jun; 57(6):1036-40. PubMed ID: 19467147
[TBL] [Abstract][Full Text] [Related]
11. [Vaccination against community acquired pneumonia in adult patients. A position paper by Neumoexpertos en Prevención].
Redondo E; Rivero I; Vargas DA; Mascarós E; Díaz-Maroto JL; Linares M; Valdepérez J; Gil A; Molina J; Jimeno I; Ocaña D; Martinón-Torres F;
Semergen; 2016 Oct; 42(7):464-475. PubMed ID: 27641310
[TBL] [Abstract][Full Text] [Related]
12. Inhaled drugs as risk factors for community-acquired pneumonia.
Almirall J; Bolíbar I; Serra-Prat M; Palomera E; Roig J; Hospital I; Carandell E; Agustí M; Ayuso P; Estela A; Torres A;
Eur Respir J; 2010 Nov; 36(5):1080-7. PubMed ID: 20525710
[TBL] [Abstract][Full Text] [Related]
13. Hospitalized community-acquired pneumonia in the elderly: an Australian case-cohort study.
Skull SA; Andrews RM; Byrnes GB; Campbell DA; Kelly HA; Brown GV; Nolan TM
Epidemiol Infect; 2009 Feb; 137(2):194-202. PubMed ID: 18559126
[TBL] [Abstract][Full Text] [Related]
14. Incidence and risk factor prevalence of community-acquired pneumonia in adults in primary care in Spain (NEUMO-ES-RISK project).
Rivero-Calle I; Pardo-Seco J; Aldaz P; Vargas DA; Mascarós E; Redondo E; Díaz-Maroto JL; Linares-Rufo M; Fierro-Alacio MJ; Gil A; Molina J; Ocaña D; Martinón-Torres F;
BMC Infect Dis; 2016 Nov; 16(1):645. PubMed ID: 27821085
[TBL] [Abstract][Full Text] [Related]
15. Is COPD associated with increased mortality and morbidity in hospitalized pneumonia? A systematic review and meta-analysis.
Jiang HL; Chen HX; Liu W; Fan T; Liu GJ; Mao B
Respirology; 2015 Oct; 20(7):1046-54. PubMed ID: 26177049
[TBL] [Abstract][Full Text] [Related]
16. Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis.
Giuliano C; Wilhelm SM; Kale-Pradhan PB
Expert Rev Clin Pharmacol; 2012 May; 5(3):337-44. PubMed ID: 22697595
[TBL] [Abstract][Full Text] [Related]
17. Pneumonia in older persons.
Loeb M
Clin Infect Dis; 2003 Nov; 37(10):1335-9. PubMed ID: 14583867
[TBL] [Abstract][Full Text] [Related]
18. Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa.
Cillóniz C; Gabarrús A; Ferrer M; Puig de la Bellacasa J; Rinaudo M; Mensa J; Niederman MS; Torres A
Chest; 2016 Aug; 150(2):415-25. PubMed ID: 27060725
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with 30-day mortality in elderly inpatients with community acquired pneumonia during 2 influenza seasons.
Torner N; Izquierdo C; Soldevila N; Toledo D; Chamorro J; Espejo E; Fernández-Sierra A; Domínguez A;
Hum Vaccin Immunother; 2017 Feb; 13(2):450-455. PubMed ID: 27924681
[TBL] [Abstract][Full Text] [Related]
20. [Risk factors for community acquired pneumonia (CAP). A systematic review].
Kohlhammer Y; Schwartz M; Raspe H; Schäfer T
Dtsch Med Wochenschr; 2005 Feb; 130(8):381-6. PubMed ID: 15717247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
